Xiamen Juda Chemical & Equipment Co, Ltd. was established in 1988. It was formerly a subsidiary of Juhua Group. Since 2004, Xiamen Juda has focused on fluorochemical business, becoming one of the first Chinese companies to export CFCs (chlorofluorocarbons), HCFCs (hydrochlorofluorocarbons), and HFCs (hydrofluorocarbons, also called HFA-hydrofluroalkane). To date, it has evolved into a comprehensive enterprise with five core product lines, including aerosols propellants, refrigerants, fire extinguishing agents, coolants, and fluoropolymers.

Xiamen Juda is one of the leading Chinese exporters of medical aerosol propellants, with over a decade of specialization in this field. Its medical grade propellants are widely used in various aerosol formulations within the pharmaceutical industry, including metered-dose inhalers, nasal sprays, oral sprays, and topical sprays. As international environmental regulations have evolved and the industry has continued to develop, medical aerosol propellants have transitioned from traditional CFCs products to the currently widely used HFC (also known as HFA) Alkane products. Xiamen Juda has closely followed these international trends, continuously providing the pharmaceutical sector with more environmentally friendly and high-quality medical aerosol propellants. It has successfully introduced Chinese CFCs and HFC (HFA) products to the international market, gaining increasing favor from renowned international pharmaceutical companies. Its export destinations cover North America, South America, Southeast Asia, Europe, the Middle East, and North Africa etc. The pharmaceutical grade aerosol propellants currently offered by Xiamen Juda include the following categories:

HFA-134A (HFC-134A) pharma grade

HFA-227EA (HFC-227EA) pharma grade

HFA-152A (HFC-152A) pharma grade

The HFA pharmaceutical propellants supplied by Xiamen Juda have obtained DMF filing with the U.S. FDA and also received the filing for pharmaceutical excipients from the National Medical Products Administration of China(China FDA). Among these, HFA-134A and HFA-227EA are currently the mainstream medical aerosol propellants in the international market. Over the next few years, as environmental protection requirements continue to strengthen, the mainstream international medical aerosol propellants are expected to gradually transition from the current dominant types to more sustainable options, such as low-carbon HFA-152A and advanced HFO-based aerosols.

Xiamen Juda will continue to adhere to the development philosophy of “serving customers and empowering the industry,” and will keep providing the global pharmaceutical sector with low-carbon, environmentally friendly, and high-quality propellant products.